Gene · 1213
Papers3,108
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,108
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lemon-Derived Extracellular Vesicles Nanodrugs Enable to Efficiently Overcome Cancer Multidrug Resistance by Endocytosis-Triggered Energy Dissipation and Energy Production Reduction. | Adv Sci (Weinh) | 2022 | 35187842 | PubTator, text mining | PubMed |
| Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer. | Nat Commun | 2022 | 35177645 | PubTator, text mining | PubMed |
| Dual clathrin and integrin signaling systems regulate growth factor receptor activation. | Nat Commun | 2022 | 35173166 | PubTator, text mining | PubMed |
| Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances. | Cancers (Basel) | 2022 | 35158892 | PubTator, text mining | PubMed |
| Recent advances of transcriptomics and proteomics in triple-negative breast cancer prognosis assessment. | J Cell Mol Med | 2022 | 35150062 | PubTator, text mining | PubMed |
| Species-dependent in vivo mRNA delivery and cellular responses to nanoparticles. | Nat Nanotechnol | 2022 | 35132167 | PubTator, text mining | PubMed |
| Proteome analysis of the circadian clock protein PERIOD2. | Proteins | 2022 | 35122331 | PubTator, text mining | PubMed |
| Surgical stabilization of the ipsilateral scapula and rib fractures using the mirror Judet approach: a preliminary result. | BMC Musculoskelet Disord | 2022 | 35101018 | PubTator, text mining | PubMed |
| Workforce problems at rural public health-centres in India: a WISN retrospective analysis and national-level modelling study. | Hum Resour Health | 2022 | 35090494 | PubTator, text mining | PubMed |
| Genome-scale CRISPR screens identify host factors that promote human coronavirus infection. | Genome Med | 2022 | 35086559 | PubTator, text mining | PubMed |
| Alternative splicing regulation of membrane trafficking genes during myogenesis. | RNA | 2022 | 35082143 | PubTator, text mining | PubMed |
| Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma. | Sci Rep | 2022 | 35075228 | PubTator, text mining | PubMed |
| siRNA Seed Region Is Divided into Two Functionally Different Domains in RNA Interference in Response to 2'-OMe Modifications. | ACS Omega | 2022 | 35071927 | PubTator, text mining | PubMed |
| Prognostic Genomic Tissue-Based Biomarkers in the Treatment of Localized Prostate Cancer. | J Pers Med | 2022 | 35055380 | PubTator, text mining | PubMed |
| Exosomal and Plasma Non-Coding RNA Signature Associated with Urinary Albumin Excretion in Hypertension. | Int J Mol Sci | 2022 | 35055008 | PubTator, text mining | PubMed |
| Reduced DNAJC3 Expression Affects Protein Translocation across the ER Membrane and Attenuates the Down-Modulating Effect of the Translocation Inhibitor Cyclotriazadisulfonamide. | Int J Mol Sci | 2022 | 35054769 | PubTator, text mining | PubMed |
| The Effects of Cranial Orientation on Forensic Frontal Sinus Identification as Assessed by Outline Analyses. | Biology (Basel) | 2022 | 35053060 | PubTator, text mining | PubMed |
| Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | Mol Syst Biol | 2022 | 35044719 | PubTator, text mining | PubMed |
| CircMET promotes tumor proliferation by enhancing CDKN2A mRNA decay and upregulating SMAD3. | Mol Cancer | 2022 | 35042525 | PubTator, text mining | PubMed |
| Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial. | Lancet Oncol | 2022 | 35038433 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1213/papers?page=31